Diagnosing spermatogonial stemness.
Diagnosing spermatogonial stemness.
复制标题
诊断精原干性。
DOI:
10.1095/biolreprod.115.129890
复制
发表时间:
2015
影响因子:
3.6
通讯作者:
Hamra,FKent
中科院分区:
文献类型:
--
作者:
Hamra,FKent
Familial health largely reflects the quality of traits transmitted by ancestral oocytes and spermatozoa. This fact of life endows gamete-producing germ cells with an intrinsic accountability for the well-being of heritable genomic architecture [1]. Consequently, it is fitting that pressure to preserve genomic integrity is reflected by lower frequencies of DNA mutations detected in germ cells than in somatic cells [2–4]. In mammals, self-renewing germline stem cells are considered unique to male gonads during reproductive life. This is because mitotically dividing female germ cells enter meiosis to differentiate into oocytes shortly after sex determination in mammals, which occurs midway through embryogenesis [5]. Oogenic arrests, together with selective oocyte degeneration, are hypothesized to provide additional safeguards that defend the germline from genomic abnormalities, highlighting the ‘‘female-protective model’’[6, 7]. In contrast, male germline stem cells, termed ‘‘spermatogonial stem cells,’’sustain spermatozoan production in testes by mitotically self-renewing over relatively long periods that span both embryonic and adult life (. 50 years in humans)[8]. Accordingly, whole-genome sequencing is providing evidence that sex-dependent increases in time given for a germline to replicate its DNA correlate strongly with longstanding observations of ‘‘male mutation bias’’[9–11]. In most species, our ability to unequivocally identify spermatogonia that replicate to function as germline stem cells has yet to be firmly established, but such a hypothesis appears fundamental to understanding cellular mechanisms that buffer the accumulation of transmittable DNA mutations by germlines [12, 13]. Scientists are rapidly annotating stem and progenitor spermatogonia in rodents [14–17], and these advances are being translated to other mammalian species, including primates [18–23]. Clinically, the ability to diagnose genomic stability in spermatogonial stem cells seems paramount in order to safely make the connection to their enormous prospective benefits for family planning and genetic medicine [24].